ADVERTISEMENT

Some patients with neuroendocrine tumours prefer quality over longevity

Deepa Koli   |   Clinical Summary   |   03 January 2023
ADVERTISEMENT

Patients with neuroendocrine tumours who may have a much longer life expectancy than those with aggressive tumours report placing a higher priority on QoL factors, such as remaining independent, compared with longer survival as a primary treatment goal. However, they often feel that their clinicians do not share their priorities, shows...

          

Topic Challenges

left
right